TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Recruiting Phase 1 Interventional Study
Mild Cognitive Impairment Alzheimer Disease Alzheimer's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of California, San Diego · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if restricting the time of eating to allow for prolonged fasting at night may reduce sleep disturbances, cognitive decay, and pathology in patients diagnosed with Mild Cognitive Impairment (MCI) or early to moderate Alzheimer's disease (AD). It will also learn about the feasibility of practicing 14 h of nightly fasting in this group of older adults. The …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Provision of signed and dated informed consent form. Stated willingness to comply with all study procedures and availability for the duration of the study. Inclusion criteria 1. Persons, aged ≥60 years 2. In good general health as evidenced by medical history or diagnosed with clinical diagnosis o…
Contacts

Paula Desplats, PhD

858-534-4839

pdesplat@health.ucsd.edu

CONTACT

Olivia Ott, M.S.

TREAD@health.ucsd.edu

CONTACT